419.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
419.2.0.1 ð Cram Sheet
419.2.0.1.1 ð¥ é« yield 12
- Whippleâs triad: symptoms + low glucose + ç·©è§£ with è£ç³
- DM Levels: 1 (<70), 2 (<54), 3 (severe, éä»äººå©)
- Adrenergic (å¿æž/æ±/æ) vs neuroglycopenic (confusion/coma)
- 15-15 rule: 15 g carb â 15 min â repeat if needed
- Severe at home: glucagon 1 mg IM/SC or nasal Baqsimi
- Severe hospital: D50 25-50 mL IV
- SU overdose: D5/D10 + octreotide 50-100 ÎŒg q6h + admit
- Hypoglycemia unawareness: avoid hypo 2-3 wk â éšå restore
- 72-h fast = insulinoma diagnostic
- Insulinoma profile: insulin â, C-peptide â, proinsulin â, β-OHB â
- Exogenous insulin: insulin â, C-peptide â (factitious)
- NICTH (IGF-2 producing tumor): large mesenchymal/HCC; insulin â
419.2.0.1.2 ð¢ å¿ è
| é ç® | æžå |
|---|---|
| Whippleâs plasma glucose | < 55 |
| DM Level 1 | < 70 |
| DM Level 2 | < 54 |
| 15-15 carb | 15 g |
| Glucagon kit | 1 mg IM |
| Glucagon nasal | 3 mg (Baqsimi) |
| D50 dose | 25-50 mL IV |
| Octreotide for SU | 50-100 ÎŒg SC q6h |
| 72-h fast cutoff | < 55 + symptoms |
| Counter-regulatory order | insulin â â glucagon â â Epi â â cortisol/GH â |
419.2.0.2 â é« yield
419.2.0.2.1 72-h Fast Interpretation
| Source | Insulin | C-peptide | Proinsulin | β-OHB |
|---|---|---|---|---|
| Insulinoma | â | â | â | â |
| Exogenous insulin (factitious) | â | â | â | â |
| Sulfonylurea | â | â | â | â + SU+ |
| NICTH (IGF-2) | â | â | â | â |
| Cortisol def | â | â | â | â |
| Glycogen def | â | â | â | varies |
419.2.0.2.2 Drug-induced Quick
| Drug | Mechanism |
|---|---|
| Insulin | Direct |
| SU/glinide | β-cell secretion |
| Alcohol | â gluconeogenesis |
| Quinolone (gati > moxi/levo) | β-cell stim |
| Pentamidine | Initial release then β-cell death |
| Quinine | β-cell stim |
| Salicylate (high dose) | â gluconeogenesis |
| ACE-i (rare) | Insulin sensitivity |
419.2.0.2.3 Insulinoma Imaging
- CT/MRI pancreas (often missed if small)
- EUS highest yield
- DOTATATE PET (SSTR+)
- GLP-1 receptor PET (specific, 22E)
- Selective intra-arterial calcium stimulation (rare)
419.2.0.2.4 Treatment Quick
| Setting | Treatment |
|---|---|
| Mild alert | 15 g carb (15-15 rule) |
| Moderate (still alert) | 15-30 g carb |
| Severe (unable swallow) | Glucagon 1 mg IM / nasal 3 mg |
| Hospital severe | D50 25-50 mL IV |
| Prolonged | D5W/D10W infusion |
| SU overdose | D5/D10 + octreotide |
| Insulinoma | Surgery (enucleation); diazoxide bridge; octreotide |
| Post-bariatric | Diet + acarbose + octreotide |
| NICTH | Tumor resection + steroid |
| Hirata syndrome | Stop offending drug + steroid + immunosuppressant |
419.2.0.3 ð¯ èªææª¢æž¬
- Whippleâs triad? â Symptoms + low glucose < 55 + è£ç³ç·©è§£
- DM Level 1/2/3? â < 70 / < 54 / éä»äºº
- 15-15 rule? â 15 g carb, 15 min check
- Severe at home? â Glucagon 1 mg IM
- Severe hospital? â D50 25-50 mL IV
- SU overdoseç¹æ®? â Octreotide
- 72-h fast cutoff? â < 55 + symptoms
- Insulinoma profile? â Insulin â, C-peptide â, β-OHB â
- Exogenous insulin clue? â C-peptide â
- NICTH? â IGF-2 producing large tumor
- Hypoglycemia unawareness restore? â Avoid hypo 2-3 wk
- Wernicke prevention? â Thiamine before glucose in alcoholic
- Insulinoma + MEN1 %? â ~10%
- Hirata syndrome? â Insulin Ab; Asian; SH-drug
- Reactive hypoglycemia? â Post-prandial; idiopathic
â ïž AI èçš¿ã